An integrated assessment of the 1,4-dioxane cancer mode of action and threshold response in rodents.

[1]  Ying Chen,et al.  Mechanistic Considerations in 1,4-Dioxane Cancer Risk Assessment. , 2022, Current opinion in environmental science & health.

[2]  Ying Chen,et al.  Oxidative Stress, Glutathione and CYP2E1 in 1,4-Dioxane Liver Cytotoxicity and Genotoxicity: Insights from Animal Models , 2022, Current Opinion in Environmental Science & Health.

[3]  C. Yauk,et al.  AOP report: Development of an adverse outcome pathway for oxidative DNA damage leading to mutations and chromosomal aberrations , 2022, Environmental and molecular mutagenesis.

[4]  Xianming Deng,et al.  Glycogen accumulation and phase separation drives liver tumor initiation , 2021, Cell.

[5]  Ying Chen,et al.  Oxidative stress and genotoxicity in 1,4-dioxane liver toxicity as evidenced in a mouse model of glutathione deficiency. , 2021, The Science of the total environment.

[6]  Virunya S Bhat,et al.  Assessing chemical carcinogenicity: hazard identification, classification, and risk assessment. Insight from a Toxicology Forum state-of-the-science workshop , 2021, Critical reviews in toxicology.

[7]  B. Lake,et al.  Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) , 2021, Critical reviews in toxicology.

[8]  Caroline H. Johnson,et al.  Identification of dose-dependent DNA damage and repair responses from subchronic exposure to 1,4-dioxane in mice using a systems analysis approach. , 2021, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  L. Haws,et al.  Transcriptomic analyses of livers from mice exposed to 1,4-dioxane for up to 90 days to assess potential mode(s) of action underlying liver tumor development , 2021, Current research in toxicology.

[10]  Caicun Zhou,et al.  Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy , 2021, Acta pharmaceutica Sinica. B.

[11]  Lisa M. Corey,et al.  A 90-day drinking water study in mice to characterize early events in the cancer mode of action of 1,4-dioxane. , 2020, Regulatory toxicology and pharmacology : RTP.

[12]  Masatoshi Watanabe,et al.  New horizons of DNA adductome for exploring environmental causes of cancer , 2020, Cancer science.

[13]  Y. Matsumoto,et al.  Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma , 2020, Cancers.

[14]  J. Corton,et al.  A Set of Six Gene Expression Biomarkers Identify Rat Liver Tumorigens in Short-Term Assays. , 2020, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  P. Steinberg,et al.  Mode of action-based risk assessment of genotoxic carcinogens , 2020, Archives of Toxicology.

[16]  J. Klaunig,et al.  Constitutive androstane receptor (CAR) mediates dieldrin-induced liver tumorigenesis in mouse , 2020, Archives of Toxicology.

[17]  S. Fukushima,et al.  Comprehensive analysis of DNA adducts (DNA adductome analysis) in the liver of rats treated with 1,4-dioxane , 2020, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[18]  R. J. Price,et al.  Piperonyl butoxide: mode of action analysis for mouse liver tumour formation and human relevance. , 2020, Toxicology.

[19]  E. Laurini,et al.  Role of Rad51 and DNA repair in cancer: A molecular perspective. , 2020, Pharmacology & therapeutics.

[20]  A. Boobis,et al.  Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge. , 2019, Regulatory toxicology and pharmacology : RTP.

[21]  A. Boobis,et al.  Chemical carcinogenicity revisited 2: Current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible. , 2019, Regulatory toxicology and pharmacology : RTP.

[22]  Andrew Williams,et al.  Using a gene expression biomarker to identify DNA damage‐inducing agents in microarray profiles , 2018, Environmental and molecular mutagenesis.

[23]  Takayoshi Suzuki,et al.  Using RNA-Seq with 11 marker genes to evaluate 1,4-dioxane compared with typical genotoxic and non-genotoxic rat hepatocarcinogens. , 2018, Mutation research. Genetic toxicology and environmental mutagenesis.

[24]  S. Fukushima,et al.  In vivo positive mutagenicity of 1,4-dioxane and quantitative analysis of its mutagenicity and carcinogenicity in rats , 2018, Archives of Toxicology.

[25]  Manoj Aggarwal,et al.  Minimum datasets to establish a CAR‐mediated mode of action for rodent liver tumors , 2018, Regulatory toxicology and pharmacology : RTP.

[26]  M. Moore,et al.  Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action , 2018, Critical reviews in toxicology.

[27]  M. LeBaron,et al.  Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor , 2017, Toxicology reports.

[28]  M. Dourson,et al.  Update: Mode of action (MOA) for liver tumors induced by oral exposure to 1,4‐dioxane , 2017, Regulatory toxicology and pharmacology : RTP.

[29]  Igor Linkov,et al.  Quantitative weight of evidence to assess confidence in potential modes of action , 2017, Regulatory toxicology and pharmacology : RTP.

[30]  E. Wakeland,et al.  RAD51 interconnects between DNA replication, DNA repair and immunity , 2017, Nucleic acids research.

[31]  H. Drexler,et al.  Metabolism and toxicokinetics of 1,4-dioxane in humans after inhalational exposure at rest and under physical stress , 2016, Archives of Toxicology.

[32]  E. Shaker,et al.  INHIBITORY ACTIVITY OF PROTECTED EDIBLE PLANTS ON OXIDATIVE STRESS INDUCED BY ORAL 1,4-DIOXANE. , 2016, Journal of the Egyptian Society of Parasitology.

[33]  M. LeBaron,et al.  Characterization of nuclear receptor-mediated murine hepatocarcinogenesis of the herbicide pronamide and its human relevance. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  Alan R. Boobis,et al.  The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events , 2014, Critical reviews in toxicology.

[35]  E. Mcconnell,et al.  Mode of action analysis for liver tumors from oral 1,4-dioxane exposures and evidence-based dose response assessment. , 2014, Regulatory toxicology and pharmacology : RTP.

[36]  Virunya S Bhat,et al.  Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  J. Corton,et al.  Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study , 2014, Critical reviews in toxicology.

[38]  T. Starr,et al.  Mode of action and dose–response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study , 2014, Critical reviews in toxicology.

[39]  Wen Xie,et al.  Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator , 2014, Critical reviews in toxicology.

[40]  M. LeBaron,et al.  An integrated approach for prospectively investigating a mode-of-action for rodent liver effects. , 2013, Toxicology and applied pharmacology.

[41]  M. Ohnishi,et al.  Distribution of 1,4-dioxane by combined inhalation plus oral exposure routes in rats , 2012 .

[42]  B. Tudek,et al.  Damage of DNA and proteins by major lipid peroxidation products in genome stability , 2012, Free radical research.

[43]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[44]  Tak Yee Aw,et al.  Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.

[45]  S. Cohen.  Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays , 2010, Toxicologic pathology.

[46]  S. Fukushima,et al.  Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[47]  S. Fukushima,et al.  Two-year inhalation study of carcinogenicity and chronic toxicity of 1,4-dioxane in male rats , 2009, Inhalation toxicology.

[48]  R. Maronpot.  Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains , 2009, Journal of toxicologic pathology.

[49]  T. Rossman,et al.  Inappropriate cytotoxicity measurements , 2009, Environmental and molecular mutagenesis.

[50]  J. Baron,et al.  Changes in Cell-Cycle Kinetics Responsible for Limiting Somatic Growth in Mice , 2008, Pediatric Research.

[51]  S. Fukushima,et al.  Thirteen-week oral toxicity of 1,4-dioxane in rats and mice. , 2008, The Journal of toxicological sciences.

[52]  S. Fukushima,et al.  Thirteen-Week Inhalation Toxicity of 1,4-Dioxane in Rats , 2008 .

[53]  Ivan Rusyn,et al.  Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[54]  M. Wyatt,et al.  Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. , 2006, Chemical research in toxicology.

[55]  H. Bartsch,et al.  Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair , 2006, Langenbeck's Archives of Surgery.

[56]  D. Eastmond,et al.  Chromosome breakage is primarily responsible for the micronuclei induced by 1,4-dioxane in the bone marrow and liver of young CD-1 mice. , 2005, Mutation research.

[57]  P. Gervasi,et al.  Effects of dioxane on cytochrome P450 enzymes in liver, kidney, lung and nasal mucosa of rat , 2005, Archives of Toxicology.

[58]  김창균,et al.  1,4-Dioxane , 2003, Definitions.

[59]  David Y. Lai,et al.  PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .

[60]  M. Ikawa,et al.  Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery , 2001, Oncogene.

[61]  M. Tsuchitani,et al.  Repeat-assessment of 1,4-dioxane in a rat-hepatocyte replicative DNA synthesis (RDS) test: evidence for stimulus of hepatocyte proliferation. , 1999, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[62]  R. Roberts.  Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences , 1999, Archives of Toxicology.

[63]  M. Okudaira,et al.  A Pathological Study on Spontaneous Hepatic Neoplasms in BDF1 Mice , 1998 .

[64]  V. Bohr,et al.  Repair of Oxidative Damage to Nuclear and Mitochondrial DNA in Mammalian Cells* , 1997, The Journal of Biological Chemistry.

[65]  Y. Uno,et al.  An in vivo-in vitro replicative DNA synthesis (RDS) test using rat hepatocytes as an early prediction assay for nongenotoxic hepatocarcinogens screening of 22 known positives and 25 noncarcinogens. , 1994, Mutation research.

[66]  K. Kleibl,et al.  Repair of O6-methylguanine and O4-methylthymine by the human and rat O6-methylguanine-DNA methyltransferases. , 1994, The Journal of biological chemistry.

[67]  G. Long,et al.  Incidence of Spontaneous Neoplastic and Nonneoplastic Lesions in Charles River CD-1® Mice Varies with Breeding Origin , 1993, Toxicologic pathology.

[68]  J. Yamate,et al.  Background pathology in BDF1 mice allowed to live out their life-span , 1990, Laboratory animals.

[69]  J. Brown,et al.  Is 1,4-dioxane a genotoxic carcinogen? , 1990, Cancer letters.

[70]  E. Mirkova.  Activity of the rodent carcinogen 1,4-dioxane in the mouse bone marrow micronucleus assay. , 1989, Mutation research.

[71]  W. Stott,et al.  Differentiation of the mechanisms of oncogenicity of 1,4-dioxane and 1,3-hexachlorobutadiene in the rat. , 1981, Toxicology and applied pharmacology.

[72]  J. Young,et al.  Dose-dependent fate of 1,4-dioxane in rats. , 1978, Journal of toxicology and environmental health.

[73]  M. Argus,et al.  Tissue and subcellular distribution of 3H-dioxane in the rat and apparent lack of microsome-catalyzed covalent binding in the target tissue. , 1977, Life sciences.

[74]  M. Argus,et al.  Structural identification of p-dioxane-2-one as the major urinary metabolite of p-dioxane , 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.

[75]  M. Argus,et al.  Metabolism in vivo of dioxane: effect of inducers and inhibitors of hepatic mixed-function oxidases. , 1977, Biochemical pharmacology.

[76]  R. Kociba,et al.  1,4-Dioxane. I. Results of a 2-year ingestion study in rats , 1974 .

[77]  R. Kociba,et al.  1,4-Dioxane. II. Results of a 2-year inhalation study in rats , 1974 .

[78]  S. Itoh,et al.  In vivo genotoxicity of 1,4-dioxane evaluated by liver and bone marrow micronucleus tests and Pig-a assay in rats. , 2019, Mutation research. Genetic toxicology and environmental mutagenesis.

[79]  M. Gerstein,et al.  RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.

[80]  T. J. Weber,et al.  Physiologically based pharmacokinetic modeling of 1,4-Dioxane in rats, mice, and humans. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[81]  T. Goldsworthy,et al.  Examination of potential mechanisms of carcinogenicity of 1,4-dioxane in rat nasal epithelial cells and hepatocytes , 2005, Archives of Toxicology.

[82]  M. Hayashi,et al.  1,4‐Dioxane is not mutagenic in five in vitro assays and mouse peripheral blood micronucleus assay, but is in mouse liver micronucleus assay , 1998, Environmental and molecular mutagenesis.

[83]  J. Grisham,et al.  Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment. , 1997, Carcinogenesis.

[84]  W. Jones,et al.  The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. , 1987, Drug metabolism reviews.

[85]  J. Young,et al.  Identification of beta-hydroxyethoxyacetic acid as the major urinary metabolite of 1,4-dioxane in the rat. , 1977, Toxicology and applied pharmacology.